NovaBridge Biosciences (NBP) Interest & Investment Income (2019 - 2025)

NovaBridge Biosciences (NBP) has reported Interest & Investment Income for 5 consecutive years, with $1.8 million the latest figure, recorded in Q4 2025.

• Quarterly Interest & Investment Income fell 18.43% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.6 million (up 1.67% YoY) and the FY2025 annual result came in at $7.6 million, up 1.67% from the prior year.
• Interest & Investment Income fell to $1.8 million in Q4 2025 per NBP's latest filing, from $2.1 million in the prior quarter.
• Over the last five years, Interest & Investment Income for NBP reached as high as $2.9 million in Q2 2023 and fell as low as $709000.0 in Q1 2024.
• A 3-year average of $2.1 million and a median of $2.1 million in 2025 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2024 — Interest & Investment Income slipped 26.24% — and 2025, when it surged 164.03%.
• Year by year, Interest & Investment Income stood at $2.3 million in 2023, then retreated by 4.69% to $2.2 million in 2024, then slipped by 18.43% to $1.8 million in 2025.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $1.8 million, $2.1 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.